Aclarion, Inc. Announces Registered Direct Offering to Fund Healthcare Technology Development
Aclarion, Inc. announces a registered direct offering of common stock priced at $9.25 per share to fund healthcare technology development. The offering is expected to raise $4.7 million and will support market and product development initiatives.
This news matters as it highlights Aclarion's strategic move to raise funds for market and product development in the healthcare technology sector. The use of biomarkers and AI algorithms to address chronic low back pain demonstrates the company's innovative approach to optimizing clinical treatments.
